Advertisement
News
Advertisement

NeuroMetrix wins final FDA clearance

Fri, 11/30/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Neurometrix Inc. (Nasdaq: NURO) has won clearance from the U.S. Food and Drug Administration for a disposable electrode used with its Sensus pain device, clearing the way for sales of the system. In August, the Waltham company won FDA clearance for the Sensus system itself, which uses transcutaneous electromagnetic nerve stimulation to ease leg pain associated with diabetic peripheral neuropathy.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading